Pharmaceuticals, Biotechnology and Life Sciences
Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.
DUBLIN–(BUSINESS WIRE)–The “KAM Metrics: Measuring Success (2019)” report has been added to ResearchAndMarkets.com’s offering. Key Account Management teams are still…
Trial met its primary objective with imeglimin observed to have a favorable safety and tolerability profile in patients with type…
– New analyses from Phase III HAVEN studies support Hemlibra’s sustained efficacy, safety and quality of life benefit in people…
Gilead will have exclusive rights to Lyndra’s platform for HIV therapies WATERTOWN, Mass.–(BUSINESS WIRE)–#Collaboration–Lyndra Therapeutics, the company making daily pills…
SWIFF-CAR, a Next Generation CAR with an Embedded On/Off-Switch Increases Safety for Patients and Extends Manufacturing Possibilities NEW YORK–(BUSINESS WIRE)–Regulatory…
WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today…
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest marketing strategy engagement…
BOSTON & SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® (ALMDT:PA) and AG Mednet have renewed…
Alfasigma USA has acquired the brand ZELNORM (tegaserod), a treatment for IBS-C, from Sloan Pharma S.à r.l. In early 2019,…